Novavax Inc (NVAX) Highlights Financial Concerns Amid Ongoing Strategic Reshaping
Shift in Strategy
The biotechnology firm has been undergoing a shift in strategy to focus more on its pipeline of vaccines, moving away from certain non-core assets.
Tag: novavax
Novavax Releases Fourth Quarter Financial Report, Exceeding Expectations
Novavax, a biotechnology company focused on developing vaccines for infectious diseases, reported its fourth quarter and full year 2023 financial results and operational highlights.
Vaccine Maker Novavax Sees Sluggish 2024 Sales, Stock Drops Sharply
Novavax, a leading vaccine maker, has reported a significant setback in its distribution plans. The company’s stock plummeted by 20% after missing quarterly estimates and predicting sluggish sales for 2024.
Novavax settles dispute with Gavi, commits to fair vaccine distribution
Novavax has successfully resolved a dispute with Gavi, the Vaccine Alliance, over the distribution of its COVID-19 vaccines. The two parties have reached a mutually beneficial agreement that will ensure the equitable distribution of Novavax’s vaccine to countries in need.
